secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001641172-25-003526
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics prices $15M public offering of 12.5M shares at $1.20 per share
--------------------------------------------------------------------------------

- Gross proceeds ~$15M from 12.5M shares at $1.20; underwriters have 45-day option for 1.875M additional shares.
- Closing expected April 11, 2025; net proceeds for working capital and general corporate purposes.
- Canaccord Genuity sole bookrunner, Maxim Group co-manager; offered under shelf registration effective Dec 2022.
- Offering significantly dilutes existing shareholders; exact dilution depends on option exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/0001641172-25-003526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000164117225003526/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer